3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Polycystic Ovary Syndrome
2
Hyperandrogenism
2
Glioblastoma
1
Interventions
Metformin
21
Inositol
13
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
salicylsalicylic acid
1
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Spironolactone
×
1 year
×
Clear all
NCT03068910
2025-08-05
CRM008
University of Virginia
Phase EARLY_PHASE1
Recruiting
32 enrolled
NCT04723862
2025-08-05
CBS010
University of Virginia
Phase EARLY_PHASE1
Recruiting
32 enrolled